Close
Show
Home Drug Research

Drug Research

This Drug Research section covers latest in Pharma drug research updates & Pharmaceutical drug research news & Pharma industry research and developments.

BioMotiv and Atomwise Sign AI Partnership to Transform Therapeutic Development

BioMotiv and Atomwise Sign AI Partnership to Transform Therapeutic Development


BioMotiv, a mission-driven pharma company part of The Harrington Project for discovery and development, and...
Astellas Announces Construction of New Manufacturing Facility for Active Pharmaceutical Ingredient of Prograf

Astellas Announces Construction of New Manufacturing Facility for Active Pharmaceutical Ingredient of Prograf


The new manufacturing facility is designed to have advanced features based on the efficiency of...
CytoviaTherapeutics and the University of California enter into a partnership to develop precision gene-edited CAR-NK celltherapy

CytoviaTherapeutics and the University of California enter into a partnership to develop precision gene-edited...


CytoviaTherapeutics,a biopharmaceutical company, and the University of California,San Francisco(UCSF) announced that they have entered a...
Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases

Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of...


Boehringer Ingelheim and Enleofen Bio Pte. Ltd. (Enleofen) announced the acquisition of worldwide exclusive rights...

BI Vaccines Announces Second Pivotal Phase 3 Study of Sci-B-Vac Meets Primary and Secondary...


VBI Vaccines Inc. (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines,...
Generation Bio Announces $110 Million Series C Financing to Advance Lead Programs for Hemophilia A and PKU

Generation Bio Announces $110 Million Series C Financing to Advance Lead Programs for Hemophilia...


Generation Bio, a company leading a new generation of gene therapy, announced the closing of...
Bayer and Exscientia collaborate to leverage the potential of AI in cardiovascular and oncology drug discovery

Bayer and Exscientia collaborate to leverage the potential of AI in cardiovascular and oncology...


Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into...
Development of First-In-Class Antibody Therapeutics and New Partnership Brings Hope to Patients with Fibrotic and Inflammatory Diseases

Development of First-In-Class Antibody Therapeutics and New Acquisition Brings Hope to Patients with Fibrotic...


The breakthrough discovery of investigational therapies for multiple human diseases by a team of Singapore...
Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics

Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies...


Velabs Therapeutics GmbH, a biotech company focused on the rapid screening of functional therapeutic antibodies...
BeiGene obtains certain rights for Leap Therapeutics cancer drug

BeiGene obtains certain rights for Leap Therapeutics cancer drug


Chinese biopharmaceutical firm BeiGene has agreed to exclusive rights to develop and commercialise Leap Therapeutics’...